Provider review
AquaVita NextGen review
Labels every tier by the supply it buys, and the shortest one is an actual month.
No figure is visible from the home page; the prices are inside the shop.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
AquaVita NextGen
$215/mo sema · $320/mo tirz, labeled one month supply
- Vs median
- $46/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The useful thing about this catalog is the label rather than the number. Each tile states what the price buys as a quantity of time — a one-month supply, a three-month supply — instead of naming a plan and leaving you to work out the billing cycle from context. That sounds minor and is not: a large share of this category prints the word month over four weeks of medication, and a page that says supply rather than plan is describing the thing being shipped rather than the subscription being sold. The shortest tier here is a genuine month. The figures themselves are mid-range, with the dual agonist carrying the usual premium over the single one, and the surrounding catalog is a general injectables shop rather than a GLP-1 specialist. What you should know before going looking is that none of this is visible from the front of the site: the home page carries no figure at all, and the prices are inside the shop. There is also no milligram anywhere, so while the period is unusually clear, the quantity of drug inside that period is not — which leaves you able to budget the month and unable to check whether the month contains the amount you intend to take.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the tier labeled by what it supplies rather than by a plan name
- You want a genuine month rather than a four-week cycle called one
- You want other injectables available from the same shop and account
Look elsewhere if
- You expect prices on the home page. They are inside the shop
- You want to know what a month's supply contains. No milligram is published
- You want a GLP-1 specialist rather than a general injectables catalog
What it actually costs
Price as published
Compounded semaglutide at $215 and compounded tirzepatide at $320, each labeled "one month supply" on the product tile, with three-month supplies listed alongside them at higher totals · ★ labeling the tier by what it supplies rather than by a plan name settles the unit question that most of this category leaves open, and the shortest tier is an actual month rather than four weeks · the wider catalog covers glutathione, NAD+ and lipotropic injections priced on the same shop page · none of these figures is on the home page. The store's product API returned HTTP 500 for both molecule queries, which is an error rather than an absence, so the shop page was walked directly and the prices read there · no milligram is published against either figure, so what quantity a month's supply contains is unstated · a returning-patient reorder flow is offered separately from the intake
- Vs median
- $46/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ Each tier is labeled by the SUPPLY it buys rather than by a plan name, and the shortest is an actual month rather than four weeks — which sounds minor and is not, given how much of this category prints the word month over a four-week cycle. A page that says supply is describing what ships rather than what is billed. None of the figures is visible from the home page; the store's product interface returned an error for both molecule queries, so the shop page was walked directly instead. No milligram is published, so the period is unusually clear and the quantity inside it is not. No low-dose product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Each tier is labeled by the supply it buys, and the shortest is an actual month.
- Both molecules are priced separately with the usual gap between them.
- A returning-patient reorder flow exists separately from the initial intake.
Pharmacy, labs and oversight
AquaVita NextGen does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What AquaVita NextGen publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The useful thing about this catalog is the label rather than the number. Each tile states what the price buys as a quantity of time — a one-month supply, a three-month supply — instead of naming a plan and leaving a reader to work out the billing cycle from context. That sounds minor and is not: a large share of this category prints the word month over four weeks of medication, and a page that says supply rather than plan is describing the thing being shipped rather than the subscription being sold. The shortest tier here is a genuine month. The figures themselves are mid-range, with the dual agonist carrying the usual premium over the single one, and the surrounding catalog is a general injectables shop rather than a GLP-1 specialist. What a reader should know before going looking is that none of this is visible from the front of the site: the home page carries no figure at all, and the prices are inside the shop. There is also no milligram anywhere, so while the period is unusually clear, the quantity of drug inside that period is not — which leaves a reader able to budget the month and unable to check whether the month contains the amount they intend to take.
The honest cons
No price is visible from the home page; the figures are inside the shop.
- No milligram is published, so what a month's supply contains is unstated.
- The GLP-1 line sits inside a general injectables catalog rather than a specialist one.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AquaVita NextGen is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#281 of 373
Ordered with the companies that pay us first, and AquaVita NextGen is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.